RECRUITING

Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV

Description

The purpose of this research study is to find out if semaglutide is safe and well tolerated in adults with cocaine use disorder who do and do not have human immunodeficiency virus (HIV). Participants will complete a screening process and if you are able to participate, you will be assigned to one of two treatment groups: semaglutide or placebo. Participants will: * Visit the clinic once a week for semaglutide or placebo injections * Visit the clinic once every two weeks for labwork, assessments and/or surveys * If consented to optional MRI's, complete two MRI's

Conditions

Cocaine Use DisorderHIV
Talk to us

Related Conditions:

Cocaine Use DisorderHIV

Study Overview

On this page

Study Details

Study overview

The purpose of this research study is to find out if semaglutide is safe and well tolerated in adults with cocaine use disorder who do and do not have human immunodeficiency virus (HIV). Participants will complete a screening process and if you are able to participate, you will be assigned to one of two treatment groups: semaglutide or placebo. Participants will: * Visit the clinic once a week for semaglutide or placebo injections * Visit the clinic once every two weeks for labwork, assessments and/or surveys * If consented to optional MRI's, complete two MRI's

Evaluation Of Semaglutide Safety and Tolerability in Adults With Cocaine Use Disorder With and Without HIV

Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV

Condition
Cocaine Use Disorder
Intervention / Treatment

-

Contacts and Locations

Washington

Institute of Human Virology at the University of Maryland School of Medicine, Washington, District of Columbia, United States, 20002

Baltimore

Institute of Human Virology at the University of Maryland School of Medicine, Baltimore, Maryland, United States, 21201

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. At least 18 years old
  • 2. Meet criteria for CUD according to the Diagnostic and Statistical Manual Version 5
  • 3. Used cocaine at least 7 out of the past 14 days
  • 4. Body Mass Index between 20 - 50 kg/m2
  • 5. English proficiency
  • 6. In people of childbearing potential, agree to use an acceptable method of birth control
  • 1. Triglycerides \> 500 mg/dL
  • 2. History of gall bladder disease
  • 3. Personal or family history of medullary thyroid carcinoma, or patients with a history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • 4. History of diabetic retinopathy
  • 5. Being prescribed glucose-lowering medications
  • 6. An estimated glomerular filtration rate of less than 45 ml/min
  • 7. Lifetime history of taking semaglutide or other GLP-1 RAs
  • 8. Current suicidal ideation or suicide attempts within the past 24 months
  • 9. Present diagnosis of diabetes mellitus OR screening hemoglobin A1C \>/= 6.5
  • 10. Use of weight-lowering medications
  • 11. History of gastric bypass surgery
  • 12. History of myocardial infarction or stroke within the past 12 months
  • 13. Pregnant, breastfeeding, or the patient intends to become pregnant during the next four months
  • 14. Any contraindicated medical issues identified by the study investigators
  • 15. Risk of conditions that are under Warning and Precautions section of OZEMPIC and WEGOVY including but not limited to known history or current report of clinically relevant hypoglycemia, gastroparesis, or pancreatic disease.
  • 16. Calcitonin value equal to or above 50 ng/L
  • 17. If completing the MRI portion of the study: claustrophobia or physical issues preventing MRI scan
  • 18. If completing the MRI portion of the study: presence of a metal device in the body (e.g. pacemaker. Infusion pump, aneurysm clip, metal prosthesis or plate

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Maryland, Baltimore,

Study Record Dates

2027-03